Patents Examined by William R. Jarvis
  • Composition and method for suppressing behavior problems of pets
    Patent number: 6297280
    Abstract: A composition for suppressing behavior problems of pets, comprising theanine, and optionally one or more compounds selected from the group consisting of highly unsaturated fatty acids and cholines; and a method of suppressing behavior problems of pets, comprising administering the above composition to a pet having behavior problems. The composition can be effectively used for suppressing various behavior problems associated with the pet.
    Type: Grant
    Filed: July 19, 2000
    Date of Patent: October 2, 2001
    Assignee: Taiyo Kagaku Co., Ltd.
    Inventors: Noriyuki Ishihara, Senji Sakanaka, Seiji Shu, Lekh Raj Juneja
  • Use of zinc salts of conjugated linoleic acids to treat skin disorders
    Patent number: 6288115
    Abstract: The invention is related to a pharmaceutical composition for use in treating skin disorders comprising substantially the zinc salt of at least one conjugated linoleic acid, wherein the composition is comprising at least 50% the zinc salt of at least one conjugated linoleic acid.
    Type: Grant
    Filed: May 9, 2000
    Date of Patent: September 11, 2001
    Assignee: Kappa Pharmaceuticals Limited
    Inventor: Derek Bryce-Smith
  • Method of treating warts using tazarotene
    Patent number: 6114348
    Abstract: A method and composition for topically treating non-metastasizing skin eruptions of warts with tazarotene in a suitable pharmaceutical composition. The compositions can include corticosteroids or fluorouracil.
    Type: Grant
    Filed: March 10, 1999
    Date of Patent: September 5, 2000
    Inventors: Paul J. Weber, Luiz B. Da Silva, Michael R. Weber
  • FXR, PPARA and LXRA activators to treat acne/acneiform conditions
    Patent number: 6071955
    Abstract: Acne vulgaris and acneiform skin conditions are treated by the application of compounds that is juvenile hormone III, 7-methyl-9-(3,3-dimethyloxiranyl)-3-methyl-2,6-nonadienoic acid methyl ester.
    Type: Grant
    Filed: February 25, 1999
    Date of Patent: June 6, 2000
    Assignee: The Regents of the University of California
    Inventors: Peter M. Elias, Karen Hanley, Kenneth R. Feingold
  • Treatment for atherosclerosis and other cardiovascular and inflammatory diseases
    Patent number: 5380747
    Abstract: Dithiocarboxylates, and in particular, dithiocarbamates, block the induced expression of the endothelial cell surface adhesion molecule VCAM-1, and are therefor useful in the treatment of cardiovascular disease, including atherosclerosis, post-angioplasty restenosis, coronary artery diseases, and angina, as well as noncardiovascular inflammatory diseases that are mediated by VCAM-1.
    Type: Grant
    Filed: October 30, 1992
    Date of Patent: January 10, 1995
    Assignee: Emory University
    Inventors: Russell M. Medford, Margaret K. Offermann, R. Wayne Alexander